Age
|
11–15
|
865
|
0.3
|
16–19
|
1654
|
0.6
|
20–29
|
20,130
|
7.1
|
30–39
|
30,492
|
10.7
|
40–49
|
34,678
|
12.2
|
50–59
|
52,509
|
18.5
|
60–69
|
58,775
|
20.7
|
70–79
|
55,791
|
19.7
|
80–89
|
25,457
|
9.0
|
90+
|
3440
|
1.2
|
Sex
|
Female
|
170,459
|
60.1
|
Male
|
113,332
|
39.9
|
Disease status
|
Any malignancy
|
20,124
|
7.1
|
Cerebrovascular disease
|
8734
|
3.1
|
Chronic pulmonary disease
|
22,454
|
7.9
|
Congestive heart failure
|
5329
|
1.9
|
Dementia
|
881
|
0.3
|
Diabetes with chronic complication
|
1571
|
0.6
|
Diabetes without chronic complication
|
18,476
|
6.5
|
Hemiplegia or paraplegia
|
1481
|
0.5
|
Metastatic solid tumour
|
4329
|
1.5
|
Mild liver disease
|
4575
|
1.6
|
Moderate or severe liver disease
|
1255
|
0.4
|
Myocardial infarction
|
9252
|
3.3
|
Peptic ulcer disease
|
4152
|
1.5
|
Peripheral vascular disease
|
5495
|
1.9
|
Renal disease
|
7449
|
2.6
|
Rheumatic disease
|
4862
|
1.7
|
Medication type
| |
0.0
|
Analgesics
|
86,839
|
30.6
|
Antidiabetic Drugs
|
27,042
|
9.5
|
Antidepressant
|
72,201
|
25.4
|
Antihypertensives
|
89,418
|
31.5
|
Cardiovascular System
|
144,363
|
50.9
|
Central Nervous System
|
130,106
|
45.8
|
Endocrine System
|
80,870
|
28.5
|
Gastro-Intestinal System
|
170,990
|
60.3
|
Infections
|
92,156
|
32.5
|
Inhaled Steroids
|
29,588
|
10.4
|
Lipid Modifying Drugs
|
67,433
|
23.8
|
Muscoskeletal And Joint Disease
|
67,483
|
23.8
|
NSAIDs including Cox-2
|
35,408
|
12.5
|
Respiratory System
|
65,127
|
22.9
|
Skin
|
71,544
|
25.2
|
Topical Steroids
|
43,186
|
15.2
|